Risk and prognosis of myocardial infarction in patients with neurofibromatosis type 1: Evidence of compromised survival
Open Access
- 23 August 2025
- journal article
- Published by Elsevier in Genetics in Medicine
- Vol. 27 (11) , 101571
Abstract
No abstract availableKeywords
Funding Information
- Terveyden ja hyvinvoinnin laitos
- Children's Tumor Foundation
- HUS Helsinki University Hospital
- Syöpäsäätiö
- Turun Yliopistollinen Keskussairaala
- Helsingin Yliopisto
- Sosiaali- ja Terveysministeriö
- Varsinais-Suomen Sairaanhoitopiiri (66/180/2012)
This publication has 34 references indexed in Scilit:
- Dentofacial Malocclusion in Neurofibromatosis 1 in FinlandAmerican Journal of Medical Genetics Part A, 2025
- Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causesMolecular Genetics & Genomic Medicine, 2023
- The rare disease neurofibromatosis 1 as a source of hereditary economic inequality: Evidence from FinlandGenetics in Medicine, 2022
- Variation and Disparities in Awareness of Myocardial Infarction Symptoms Among Adults in the United StatesJAMA Network Open, 2019
- Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumoursEuropean Journal of Cancer, 2017
- Predicting Coronary Heart Disease and Stroke: The FINRISK CalculatorGlobal Heart, 2016
- Socioeconomic Indicators and the Risk of Acute Coronary Heart Disease Events: Comparison of Population-Based Data from the United States and FinlandAnnals of Epidemiology, 2011
- Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register serviceAmerican Journal of Medical Genetics Part A, 2010
- Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscleNeurobiology of Disease, 1995
- The neurofibromatosis type 1 gene encodes a protein related to GAPCell, 1990